Agios Pharmaceuticals, Inc.
) was a big mover last session, as the company saw its shares
rise by roughly 19% on the day. The move came on solid volume too
with far more shares changing hands than in a normal session.
This continues the recent uptrend of the company as the stock has
now gained over 87% since Jan 6.
This biotechnology company has seen no estimate revision over the
past 30 days and its Zacks Consensus Estimate remained unchanged
over the same time frame. The recent price action is encouraging
though, so make sure to keep a close watch on this firm in the
Agios Pharmaceuticals currently has a Zacks Rank #3 (Hold) while
Some better-ranked stocks in the same industry include
Cardiovascular Systems Inc.
Mead Johnson Nutrition Company
). While Cardiovascular Systems and Mead Johnson Nutrition
Company hold a Zacks Rank #1 (Strong Buy), Advaxis carries a
Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research?
Today, you can download
7 Best Stocks for the Next 30 Days.
Click to get this free report >>
ADVAXIS INC (ADXS): Get Free Report
AGIOS PHARMACT (AGIO): Free Stock Analysis
CARDIOVASCLR SY (CSII): Free Stock Analysis
MEAD JOHNSON NU (MJN): Free Stock Analysis
To read this article on Zacks.com click here.